GlaxoSmithKline (GSK)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

1,749.50p
   
  • Change Today:
      7.50p
  • 52 Week High: 1,773.00p
  • 52 Week Low: 1,317.50p
  • Currency: UK Pounds
  • Shares Issued: 4,927.46m
  • Volume: 4,614,446
  • Market Cap: £86,206m
  • RiskGrade: 81
  • Beta: 0.58

Latest ShareCast News

Wednesday broker round-up UPDATE

Date: Wednesday 22 May 2013

Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation.

GlaxoSmithKline ShareCast News

Glaxo hit by US regulatory delay 01-May-2013 ShareCast
Tuesday broker round-up UPDATE 30-Apr-2013 ShareCast
GlaxoSmithKline submits application for COPD dru... 26-Apr-2013 ShareCast
GSK advances on plans to sell Lucozade and Riben... 24-Apr-2013 ShareCast
Monday broker round-up UPDATE 22-Apr-2013 ShareCast

GlaxoSmithKline Regulatory News

Transaction in Own Shares 24-May-2013 17:11 RNS
Transaction in Own Shares 23-May-2013 17:18 RNS
Transaction in Own Shares 21-May-2013 17:16 RNS
Transaction in Own Shares 20-May-2013 17:14 RNS
Transaction in Own Shares 17-May-2013 17:58 RNS

GlaxoSmithKline Newspaper Links

Glaxo wins £1.5m grant 20-Dec-2011 The Herald
GSK embarks on a new age of discovery 12-Dec-2011 Telegraph
How boardroom excess is eroding trust in business 22-Nov-2011 Guardian
GlaxoSmithKline scientists face their own Dragon... 07-Nov-2011 Telegraph
GlaxoSmithKline pays £1.9bn to settle US legal i... 04-Nov-2011 Guardian

GlaxoSmithKline Tips & Analysis

Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent
Questor : GlaxoSmithKline 03-May-2011 Telegraph

GlaxoSmithKline News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Other GlaxoSmithKline News

FTSE 100 preview: Greek delay hits shares 20-Jun-2011 This Is Money
GlaxoSmithKline gets green light over Potiga 14-Jun-2011 This Is Money

Irish zinc explorer Connemara Mining ...

11-Jun-2011 Proactive Investors
FTSE preview: Gloom over commodities 10-Jun-2011 This Is Money
FTSE preview: Shares hit by US jobs woe 06-Jun-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,749.50p
Change Today 7.50p
% Change 0.43 %
52 Week High 1,773.00p
52 Week Low 1,317.50p
Volume 4,614,446
Shares Issued 4,927.46m
Market Cap £86,206m
Beta 0.58
RiskGrade 81

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.33% below the market average66.33% below the market average66.33% below the market average66.33% below the market average66.33% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
61.19% above the market average61.19% above the market average61.19% above the market average61.19% above the market average61.19% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income
72.21% above the market average72.21% above the market average72.21% above the market average72.21% above the market average72.21% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
16.49% below the market average16.49% below the market average16.49% below the market average16.49% below the market average16.49% below the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average

What The Brokers Say

Strong Buy 9
Buy 1
Neutral 14
Sell 2
Strong Sell 4
Total 30
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 08-May-13 20-Feb-13
Paid 11-Jul-13 11-Apr-13
Amount 18.00p 22.00p

Trades for 24-May-2013

Time Volume / Share Price
16:41 25,517 @ 1,749.50p
16:41 17,996 @ 1,738.07p
16:41 19,567 @ 1,736.24p
16:37 6,665 @ 1,731.88p
16:35 1,423,426 @ 1,749.50p

GlaxoSmithKline Key Personnel

CEO Sir Andrew P Witty

Top of Page